Insider Shareholders with Direct Ownership of Infinity Pharmaceuticals, Inc. (INFI)
This section provides a comprehensive overview of the insiders with direct ownership of Infinity Pharmaceuticals, Inc. (INFI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
INFINITY PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Adelene Q Perkins
Director |
768,133 | 410,196 | 1,175,291 $0 | 2 |
Sep 12, 2023
Reduced 25.87%
|
|
Bvf Partners L P
> 10% Shareholder |
9,702,895 | 8,108,605 | 534,847 $0 | 15 |
Feb 11, 2021
Reduced 22.14%
|
| 49,439 | 0 | 215,403 $0 | 2 |
Jun 16, 2022
Added 17.72%
|
|
|
Stephane Peluso
Chief Scientific Officer |
64,994 | 0 | 37,052 $0 | 1 |
Aug 02, 2022
Added 28.81%
|
| 30,919 | 0 | 30,919 $0 | 1 |
Jun 16, 2022
Added 50.0%
|
|
| 5,000 | 0 | 15,000 $0 | 1 |
May 14, 2021
Added 25.0%
|
|
| 3,061 | 0 | 8,775 $0 | 1 |
Jun 10, 2021
Added 25.86%
|